ArticleCureus2026
Treatment Compliance Among People With Type 2 Diabetes in Rural Tamil Nadu, India: Prevalence, Associated Factors, and a Comparison of Public and Private Care.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTreatment compliance determines whether therapy for type 2 diabetes succeeds in practice, yet it is poorly characterized in rural India, where free public services and fee-charging private services operate side by side. We estimated the prevalence of treatment compliance, identified its independent correlates, and compared compliance between government and private facilities in a rural community of Tamil Nadu.
methodsIn this community-based cross-sectional study, 220 adults with type 2 diabetes on treatment for at least three months were selected by simple random sampling. Compliance was measured with the nine-item Hill-Bone Medication Adherence Scale and dichotomized at the sample median. Independent correlates were identified by binary logistic regression, and the most recent fasting and post-prandial blood glucose values were retrieved as an objective correlate. Associations were tested with the chi-squared and Fisher exact tests and the Mann-Whitney U test, with p < 0.05 considered significant.
resultsOnly 34.1% of participants were compliant. Compliant patients had markedly lower fasting glucose (143 vs. 181 mg/dL) and post-prandial glucose (236 vs. 295 mg/dL; both p < 0.001). In multivariable analysis, only a diabetes duration exceeding 10 years independently predicted compliance (adjusted odds ratio 3.39, 95% confidence interval (CI) 1.55-7.40; p = 0.002); the univariate associations with age and travel time did not persist after adjustment. Compliance was almost identical in government and private facilities (34.4% vs. 33.7%; p = 0.907), even though 24.5% of private-care users reported being unable to afford treatment, and it was unrelated to sex, education, occupation, or socioeconomic class.
conclusionsTwo-thirds of rural adults with type 2 diabetes were non-compliant, and non-compliance was mirrored in significantly worse glycemic control. Public and private care achieved equal compliance despite an unequal cost burden, and only longer disease experience distinguished compliant patients. Duration-sensitive adherence support that engages the recently diagnosed, delivered across both care streams, is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.